Home
> Dietary supplements | Search
|
Pharmaceutical Journal |
|
Dietary supplements summary |
(2) Green teaDescription Green tea is prepared from the steamed and dried leaves of Camellia sinensis, a shrub which grows in eastern Asia. Green tea contains polyphenols (catechins), tannins and methyl-xanthines (eg, caffeine, theophylline, theobromine). Green tea extract is available in tablets and capsules with typical doses of 100–300mg (as catechins). Action Green tea reportedly has antioxidant properties, attributed primarily to the polyphenols, and protects against damage to cells. High consumption of green tea has been linked with a reduction in low-density lipoprotein (LDL) cholesterol, a decrease in the oxidation of LDL, an increase in high-density lipoprotein (HDL) cholesterol, and inhibition of thromboxane formation and platelet aggregation. Green tea polyphenolics have been shown to have anticarcinogenic and antibacterial properties in vitro and in animals. Reported uses Chinese and Japanese populations have used green tea and its extract for thousands of years. Claims for this substance include the prevention of cardiovascular disease, cancer, viral and bacterial infections (including AIDS) and dental caries. Epidemiological studies have linked high intakes of green tea with decreased risk of atherogenesis and cardiovascular disease, but controlled trials using green tea as a drink or supplement in humans have failed to show a substantial lipid lowering effect. Preliminary associations (from epidemiological research) have been made between higher green tea consumption and reduced incidence of cancers of the breast, prostate, stomach, pancreas, colon and lung, but further research is needed to confirm this effect. Green tea can be recommended as a healthy drink, but there is far less research on green tea supplements, and more research is needed on their safety and efficacy before definite recommendations for their value can be made. Adverse effects None known. Precautions Hypersensitivity to green tea. Pregnant and breast-feeding women should avoid green tea supplements pending long-term safety studies. Use with caution in people with a history of bleeding or haemostatic disorders. Interactions Theoretically, green tea may enhance the effect of drugs affecting coagulation or platelet aggregation (eg, aspirin, warfarin, clopidogrel).
|
Home | Journals | News | Notice-board | Search | Jobs Classifieds | Site
Map | Contact us
©The Pharmaceutical Journal